Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 11472875
Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereof
granted -
US 11471398
Devices and methods for delivering therapeutics
granted -
US 11471449
Use of pridopidine to improve cognitive function and for treating Alzheimer's disease
granted -
US 11472861
Methods for producing aflibercept in chemically defined media having reduced aflibercept variants
granted -
US 11472888
Reelin antibodies for treatment of atherosclerosis
granted -
US 11472842
Analogues of hepcidin mimetics with improved in vivo half lives
granted -
US 11472813
OX2R compounds
granted -
US 11472812
Anti-cancer compounds targeting Ral GTPases and methods of using the same
granted -
US 11471464
Pharmaceutical compositions comprising meloxicam
granted -
US 11471528
Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation
granted -
US 11472889
Antibodies, activatable antibodies, bispecific antibodies, and bispecific activatable antibodies and methods of use thereof
granted -
US 11464719
Cosmetic and dermatological compositions
granted -
US 11464815
Dengue vaccine unit dose and administration thereof
granted -
US 11464845
Neisseria meningitidis immunogenic compositions
granted -
US 11464830
Treatment of inflammatory conditions by delivery of interleukin-1 receptor antagonist fusion protein
granted -
US 11464869
Non-adult human dosing of brentuximab vedotin
granted -
US 11464856
Combination therapy using inhibitors of human growth and differentiation factor 15 (GDF-15) and immune checkpoint blockers
granted -
US 11464812
Synergistic bacterial compositions and methods of production and use thereof
granted -
US 11464801
Compositions and methods for treating cancer with anti-CD33 immunotherapy
granted -
US 11464807
Genetically engineered hematopoietic stem cells and uses thereof
granted -
US 11464795
Saponin compound targeting PD-1 and application thereof
granted -
US 11464802
3-substituted piperidine compounds for Cbl-b inhibition, and use thereof
granted -
US 11464841
TERT immunogenic compositions and methods of treatment using the same
granted -
US 11465994
MGluR7 agonist compounds for treating mGluR7-regulated diseases, disorders, or conditions
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.